Renascience Inc. (TYO:4889)
Japan · Delayed Price · Currency is JPY 1,446.00
-24.00 (-1.63%)
At close: Apr 17, 2026
Renascience Market Cap
Renascience has a market cap or net worth of 19.92 billion as of April 17, 2026. Its market cap has increased by 38.69% in one year.
Market Cap
19.92B
Enterprise Value
17.50B
Revenue
107.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,446.00
Market Cap Chart
Since September 24, 2021, Renascience's market cap has increased from 10.13B to 19.92B, an increase of 96.58%. That is a compound annual growth rate of 15.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 19.92B | 8.33% |
| Dec 30, 2025 | 18.39B | 387.08% |
| Dec 30, 2024 | 3.78B | -31.57% |
| Dec 29, 2023 | 5.52B | 18.26% |
| Dec 30, 2022 | 4.67B | -46.27% |
| Dec 30, 2021 | 8.68B | -14.33% |
| Sep 24, 2021 | 10.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Japan Tissue Engineering | 24.65B |
| Stella Pharma | 24.27B |
| AnGes | 22.55B |
| RaQualia Pharma | 22.27B |
| StemRIM | 19.49B |
| ReproCELL | 17.11B |
| CanBas | 14.22B |
| Immuno-Biological Laboratories | 14.06B |